Vor Biopharma Stock Target Price and Analyst Consensus
| VOR Stock | USD 2.09 0.04 1.95% |
The current analyst and expert consensus on Vor Biopharma is Hold with 5 hold recommendations. The current projected Vor Biopharma target price consensus is 0.32 with 5 analyst opinions. One of the most common ways Vor Biopharma analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Vor Biopharma vendors, executives, and/or customers. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Vor Biopharma. We strongly encourage you to use your own analysis of Vor Biopharma to validate this buy or sell advice. Vor Biopharma recommendation module provides expert sentiment on the projected Vor Biopharma target price to derive its highest and lowest estimates based on target price standard deviation of 19.2137.
Lowest Forecast 0.29 | Highest Forecast 0.35 | Target Price 0.32 |
It's important to approach Vor Biopharma's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Vor Biopharma Target Price Consensus
Vor target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Vor Biopharma's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 5 | Hold |
Most Vor analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Vor stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Vor Biopharma, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationVor Biopharma Target Price Projection
Vor Biopharma's current and average target prices are 2.09 and 0.32, respectively. The current price of Vor Biopharma is the price at which Vor Biopharma is currently trading. On the other hand, Vor Biopharma's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Vor Biopharma Target Price
Vor Biopharma Analyst Ratings
Vor Biopharma's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Vor Biopharma stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Vor Biopharma's financials, market performance, and future outlook by experienced professionals. Vor Biopharma's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Vor Biopharma price targets
Vor Biopharma's stock target price is an estimate of its future price, usually made by analysts. Using Vor Biopharma's target price to determine if it is a suitable investment can be done through the following steps:- Look at Vor Biopharma's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Vor Biopharma's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Vor Biopharma Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Vor Biopharma is a key component of Vor Biopharma valuation and have some predictive power on the future returns of a Vor Biopharma.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Power Assets Invested over 90 shares | |
 | Petroleum and Natural Gas Invested over 90 shares | |
 | Communication Invested over 90 shares | |
 | Dividend Beast Invested over 90 shares | |
 | Information Technology ETFs Invested over 90 shares | |
 | Macroaxis Index Invested over 90 shares | |
 | Banks Invested over 90 shares | |
 | Giant Impact Invested few shares | |
 | Measuring and Control Equipment Invested few shares | |
 | Steel Works Etc Invested over 90 shares | |
 | Robots And Drones Invested a lot of shares |
Additional Tools for Vor Stock Analysis
When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.